Engkang, Humaydi A.
HRN: 22-34-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2022
FLUCONAZOLE 150MG (CAP)
12/21/2022
01/03/2023
PO
150mg
OD
Oral Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes